Vestibular Consequences of Blast-related Mild Traumatic Brain Injury (TBI)

Status Completed

Clinical Trial Summary

The purpose of this project is to determine the effects of mild traumatic brain injury and blast exposure on the inner ear balance and central nervous systems.

Clinical Trial Description

The goal of this project is to determine the effects of mild traumatic brain injury (mTBI) and blast exposure on the vestibular system and CNS. Dizziness and balance disorders are common symptoms associated with mTBI or head injury. Numerous studies have provided significant evidence that mTBI or head injury can cause damage to the vestibular system; however, most have limited the vestibular evaluation to assessment of horizontal semicircular canal function. Recently, methods have been developed to assess otolith function, and there is some evidence that head injury may affect the otolith organs to a greater degree than the semicircular canals.

mTBI has been called the signature condition of Veterans returning from Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF), and the cause is often related to blast exposure from improvised explosive devices, mortars or rocket-propelled grenades. Some investigators have presumed that dizziness and balance disorders following blast exposure are related to CNS damage caused by the TBI rather than the pressure wave from the blast injury. Thus, most research has focused on the vestibular consequences of TBI (or head injury), and there is limited data on the effects of blast exposure on vestibular function or balance. Recently, magnetic resonance imaging techniques have been developed that may allow for testing the assumption that the symptoms of dizziness or imbalance related to head injury or blast exposure are often due to central vestibular or CNS involvement.

Specific aims of this project are to determine the effect of mTBI and blast exposure on (1) peripheral vestibular system function (specifically, horizontal semicircular canal function, and otolith organ function), (2) central vestibular/CNS function, (3) postural stability, and (4) dizziness-related quality of life. Four subject groups will include Veterans complaining of dizziness/imbalance with (1) a history of blast exposure, (2) with mTBI, (3) with blast exposure and mTBI, and (4) a control group. Each subject will undergo tests of horizontal semicircular canal function (caloric and rotary chair), tests of otolith function (vestibular evoked myogenic potentials, subjective visual vertical), central vestibular function/CNS function (ocular motor tests, diffusion tensor and susceptibility weighting imaging), gait and balance testing, and the Dizziness Handicap Inventory. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01021137
Study type	Observational
Source	VA Office of Research and Development
Contact
Status	Completed
Phase
Start date	May 1, 2011
Completion date	December 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02710123` - Sub-Threshold Exercise Treatment for Adolescents With Sports Related Concussion	N/A
Recruiting	`NCT02777060` - Exploring the Effectiveness of Sensor-based Balance Training on Patient Outcome Measures	N/A
Completed	`NCT02262286` - MIND (Management of Traumatic Brain Injury Diagnosis)	N/A
Completed	`NCT01461902` - Vasospasm in Pediatric Traumatic Brain Injury	N/A
Recruiting	`NCT01198964` - Optimization of Human Cortical Stimulation
Active, not recruiting	`NCT01207050` - Effect of Rozerem on Sleep Among People With Traumatic Brain Injury	Phase 4
Completed	`NCT01201863` - Neuroendocrine Dysfunction in Traumatic Brain Injury: Effects of Testosterone Therapy	Phase 4
Completed	`NCT00875329` - Traumatic Brain Injury (TBI) Screening Instruments	N/A
Completed	`NCT01059890` - Cerebral Antibiotics Distribution After Acute Brain Injury	Phase 1
Completed	`NCT01035606` - Training in Goal-directed Attention Regulation for Individuals With Brain Injury	N/A
Completed	`NCT00596765` - Neuropsychological Cognitive Behavioral Therapy for Patients With Acquired Brain Injury	N/A
Completed	`NCT00571623` - Automated Chest Physiotherapy to Improve Outcomes in Neuro	N/A
Completed	`NCT00336466` - The Erythropoietin NeuroProtective Effect: Assessment in CABG Surgery (TENPEAKS)	Phase 2
Recruiting	`NCT05105763` - Biofeedback Gait Retraining for Stiff Knee Gait Correction	N/A
Recruiting	`NCT02495558` - Cough Assessment in Patients With Severe Acquired Brain Injury	N/A
Completed	`NCT02100592` - Early Verticalization in neuroICU With ERIGO: a Safety and Feasibility Study	Phase 1/Phase 2
Completed	`NCT00797680` - Duration of Hypothermia for Neuroprotection After Pediatric Cardiac Arrest	Phase 2
Completed	`NCT00018499` - Genotype Influence on Recovery After Traumatic Brain Injury	N/A
Recruiting	`NCT02567201` - Electrophysiological Evaluation of Voluntary Attention	N/A
Withdrawn	`NCT05581927` - Whole-Body Hypothermia for Neonates With Hypoxic-Ischemic Encephalopathy(HIE)	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.